GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BB Biotech AG (HAM:BBZA) » Definitions » Cyclically Adjusted Book per Share

BB Biotech AG (HAM:BBZA) Cyclically Adjusted Book per Share : €0.00 (As of Mar. 2025)


View and export this data going back to 2008. Start your Free Trial

What is BB Biotech AG Cyclically Adjusted Book per Share?

Note: As Cyclically Adjusted Book per Share is a main component used to calculate Cyclically Adjusted PB Ratio. If the month end stock price for this stock is zero, result may not be accurate due to the exchange rate between different shares and the data will not be stored into our database. Selected historical data showed in the calculation section below is only for demostration purpose.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

BB Biotech AG's adjusted book value per share for the three months ended in Mar. 2025 was €37.219. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €0.00 for the trailing ten years ended in Mar. 2025.

During the past 12 months, BB Biotech AG's average Cyclically Adjusted Book Growth Rate was 5.10% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 6.40% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 5.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of BB Biotech AG was 6.40% per year. The lowest was 3.10% per year. And the median was 4.80% per year.

As of today (2025-07-19), BB Biotech AG's current stock price is €33.50. BB Biotech AG's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 was €0.00. BB Biotech AG's Cyclically Adjusted PB Ratio of today is .

During the past 13 years, the highest Cyclically Adjusted PB Ratio of BB Biotech AG was 1.27. The lowest was 0.42. And the median was 1.14.


BB Biotech AG Cyclically Adjusted Book per Share Historical Data

The historical data trend for BB Biotech AG's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BB Biotech AG Cyclically Adjusted Book per Share Chart

BB Biotech AG Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

BB Biotech AG Quarterly Data
Dec17 Dec18 Dec19 Dec20 Mar21 Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of BB Biotech AG's Cyclically Adjusted Book per Share

For the Biotechnology subindustry, BB Biotech AG's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BB Biotech AG's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BB Biotech AG's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where BB Biotech AG's Cyclically Adjusted PB Ratio falls into.


;
;

BB Biotech AG Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, BB Biotech AG's adjusted Book Value per Share data for the three months ended in Mar. 2025 was:

Adj_Book= Book Value per Share /CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=37.219/107.7224*107.7224
=37.219

Current CPI (Mar. 2025) = 107.7224.

BB Biotech AG Quarterly Data

Book Value per Share CPI Adj_Book
201209 100.474 101.392 106.747
201212 89.853 100.968 95.864
201303 96.554 101.221 102.755
201306 115.184 101.466 122.286
201309 23.184 101.336 24.645
201312 25.376 101.036 27.055
201403 25.282 101.224 26.905
201406 27.660 101.517 29.351
201409 33.797 101.247 35.959
201412 51.480 100.704 55.068
201503 62.074 100.339 66.642
201506 68.801 100.464 73.772
201509 57.035 99.785 61.572
201512 65.895 99.386 71.422
201603 42.928 99.475 46.487
201606 43.651 100.088 46.981
201609 50.051 99.604 54.130
201612 50.424 99.380 54.657
201703 54.383 100.040 58.559
201706 55.243 100.285 59.340
201712 54.685 100.213 58.783
201812 46.141 100.906 49.258
201912 56.097 101.063 59.793
202012 64.928 100.241 69.774
202103 0.000 100.800 0.000
202106 0.000 101.352 0.000
202112 57.062 101.776 60.396
202203 48.928 103.205 51.070
202206 44.678 104.783 45.931
202209 0.000 104.835 0.000
202212 49.628 104.666 51.077
202303 41.879 106.245 42.461
202306 42.287 106.576 42.742
202309 42.048 106.570 42.503
202312 44.916 106.461 45.448
202403 46.702 107.355 46.862
202406 45.235 107.991 45.123
202409 43.237 107.468 43.339
202412 44.718 107.128 44.966
202503 37.219 107.722 37.219

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


BB Biotech AG  (HAM:BBZA) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of BB Biotech AG was 1.27. The lowest was 0.42. And the median was 1.14.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


BB Biotech AG Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of BB Biotech AG's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


BB Biotech AG Business Description

Industry
Traded in Other Exchanges
Address
Schwertstrasse 6, Schaffhausen, CHE, CH-8200
BB Biotech AG is a part of the healthcare sector in Switzerland. Its primary activity includes making investments, especially in the biotechnology market, and is one of the investors in the field of biotechnology. The focus of the investments is on those listed companies that focus on the development and marketing of novel drugs with a clear value for the healthcare system.

BB Biotech AG Headlines

No Headlines